The incidence of thyroid cancer in semaglutide-treated patients was less than 1%, suggesting no significant risk
Biochem Mol Med 60(2):142148 Laplante M, Sabatini DM (2012) mTOR Signaling
The Sustain trials, which followed thousands of patients with type 2 diabetes over 30 weeks, showed that semaglutide reduced HbA1c (long-term blood sugar marker) by 1.5 to 2.0 percentage points compared to placebo
These larger, longer-duration studies will provide more definitive data on efficacy, durability of response, and the compounds broader metabolic profile
Your BPC-157 vial has arrived
Where it tends to fall behind is during periods of extra demand: chronic stress, frequent immune challenges, exposure to environmental toxins, or simply getting older, since glutathione status naturally tends to decline with age.* People who tend to be drawn to this product include those focused on liver and detox support, anyone who's tried a standard glutathione capsule and felt like nothing happened, and people who prefer liquid supplements over pills to begin with